Reclassification of smears originally classified as negative as atypical squamous cells of undetermined significance in quality assurance reviews is problematic and contributes little to assessing laboratory performance. See also pages 319–21 and 351–3.
No takes yet. Share an insight, caveat, or question.
Stanley et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: